ICD-10 Code for Endometrial Adenocarcinoma: C54

ICD-10 Codes for Endometrial Adenocarcinoma

The International Classification of Diseases, 10th Revision (ICD-10), is a medical classification system that is used to code diagnoses and procedures. The ICD-10 code for endometrial adenocarcinoma is C54.

ICD-10 Code for Endometrial Adenocarcinoma, NOS

• C54.9 Endometrial adenocarcinoma, unspecified

ICD-10 Codes for Endometrial Adenocarcinoma by Histologic Type

• C54.0 Endometrioid adenocarcinoma
• C54.1 Serous adenocarcinoma
• C54.2 Clear cell adenocarcinoma
• C54.3 Mucinous adenocarcinoma
• C54.4 Adenosquamous carcinoma
• C54.5 Undifferentiated carcinoma
• C54.6 Other specified endometrial adenocarcinoma
• C54.7 Endometrial adenocarcinoma with squamous metaplasia
• C54.8 Endometrial adenocarcinoma with villoglandular pattern

ICD-10 Codes for Endometrial Adenocarcinoma with Specified Behavior

• C54.00 Endometrioid adenocarcinoma, in situ
• C54.01 Endometrioid adenocarcinoma, localized
• C54.02 Endometrioid adenocarcinoma, regional spread
• C54.03 Endometrioid adenocarcinoma, distant metastasis
• C54.10 Serous adenocarcinoma, in situ
• C54.11 Serous adenocarcinoma, localized
• C54.12 Serous adenocarcinoma, regional spread
• C54.13 Serous adenocarcinoma, distant metastasis
• C54.20 Clear cell adenocarcinoma, in situ
• C54.21 Clear cell adenocarcinoma, localized
• C54.22 Clear cell adenocarcinoma, regional spread
• C54.23 Clear cell adenocarcinoma, distant metastasis
• C54.30 Mucinous adenocarcinoma, in situ
• C54.31 Mucinous adenocarcinoma, localized
• C54.32 Mucinous adenocarcinoma, regional spread
• C54.33 Mucinous adenocarcinoma, distant metastasis
• C54.40 Adenosquamous carcinoma, in situ
• C54.41 Adenosquamous carcinoma, localized
• C54.42 Adenosquamous carcinoma, regional spread
• C54.43 Adenosquamous carcinoma, distant metastasis
• C54.50 Undifferentiated carcinoma, in situ
• C54.51 Undifferentiated carcinoma, localized
• C54.52 Undifferentiated carcinoma, regional spread
• C54.53 Undifferentiated carcinoma, distant metastasis
• C54.60 Other specified endometrial adenocarcinoma, in situ
• C54.61 Other specified endometrial adenocarcinoma, localized
• C54.62 Other specified endometrial adenocarcinoma, regional spread
• C54.63 Other specified endometrial adenocarcinoma, distant metastasis
• C54.70 Endometrial adenocarcinoma with squamous metaplasia, in situ
• C54.71 Endometrial adenocarcinoma with squamous metaplasia, localized
• C54.72 Endometrial adenocarcinoma with squamous metaplasia, regional spread
• C54.73 Endometrial adenocarcinoma with squamous metaplasia, distant metastasis
• C54.80 Endometrial adenocarcinoma with villoglandular pattern, in situ
• C54.81 Endometrial adenocarcinoma with villoglandular pattern, localized
• C54.82 Endometrial adenocarcinoma with villoglandular pattern, regional spread
• C54.83 Endometrial adenocarcinoma with villoglandular pattern, distant metastasis

Epidemiology of Endometrial Adenocarcinoma

Endometrial adenocarcinoma is the most common type of uterine cancer. It is estimated that there will be 65,620 new cases of endometrial cancer in the United States in 2023, and that 12,550 women will die from the disease.

The incidence of endometrial adenocarcinoma is increasing, and this is thought to be due to the increasing prevalence of obesity and diabetes. These conditions are associated with an increased risk of endometrial cancer, as they can lead to the overproduction of estrogen, which can stimulate the growth of endometrial cells.

Risk Factors for Endometrial Adenocarcinoma

The risk factors for endometrial adenocarcinoma include:

• Obesity
• Diabetes
• Age (most cases occur in women over the age of 50)
• Nulliparity (never having children)
• Late menopause
• Estrogen replacement therapy
• Tamoxifen use
• Lynch syndrome

Symptoms of Endometrial Adenocarcinoma

The most common symptom of endometrial adenocarcinoma is vaginal bleeding after menopause. Other symptoms can include:

• Pelvic pain
• Abdominal pain
• Bloating
• Weight loss
• Fatigue

Diagnosis of Endometrial Adenocarcinoma

Endometrial adenocarcinoma is diagnosed with a biopsy. A biopsy is a procedure in which a small sample of tissue is removed from the uterus and examined under a microscope.

Treatment of Endometrial Adenocarcinoma

The treatment of endometrial adenocarcinoma depends on the stage of the disease. The stages of endometrial adenocarcinoma are:

• Stage I: The cancer is confined to the uterus.
• Stage II: The cancer has spread to the cervix or the upper vagina.
• Stage III: The cancer has spread to the pelvic lymph nodes or the ovaries.
• Stage IV: The cancer has spread to other organs, such as the lungs or liver.

The treatment options for endometrial adenocarcinoma include:

• Surgery: Surgery is the main treatment for endometrial adenocarcinoma. The type of surgery will depend on the stage of the disease.
• Radiation therapy: Radiation therapy uses high-energy X-rays to kill cancer cells. Radiation therapy can be used before or after surgery.
• Chemotherapy: Chemotherapy uses drugs to kill cancer cells. Chemotherapy can be used before or after surgery, or it can be used as a palliative treatment to relieve symptoms.
• Hormone therapy: Hormone therapy uses hormones to block the growth of cancer cells. Hormone therapy can be used after surgery to reduce the risk of recurrence.

Prognosis for Endometrial Adenocarcinoma

The prognosis for endometrial adenocarcinoma depends on the stage of the disease at the time of diagnosis. The 5-year survival rate for endometrial adenocarcinoma is:

• Stage I: 95%
• Stage II: 85%
• Stage III: 70%
• Stage IV: 15%

Prevention of Endometrial Adenocarcinoma

There is no sure way to prevent endometrial adenocarcinoma, but there are some things you can do to reduce your risk, such as:

• Maintaining a healthy weight
• Exercising regularly
• Eating a healthy diet
• Limiting alcohol intake
• Avoiding smoking
• Getting regular Pap tests

Conclusion

Endometrial adenocarcinoma is the most common type of uterine cancer. The incidence of endometrial adenocarcinoma is increasing, and this is thought to be due to the increasing prevalence of obesity and diabetes. The risk factors for endometrial adenocarcinoma include obesity, diabetes, age, nulliparity, late menopause, estrogen replacement therapy, tamoxifen use, and Lynch syndrome. The most common symptom of endometrial adenocarcinoma is vaginal bleeding after menopause. Endometrial adenocarcinoma is diagnosed with a biopsy. The treatment of endometrial adenocarcinoma depends on the stage of the disease. The prognosis for endometrial adenocarcinoma depends on the stage of the disease at the time of diagnosis. There is no sure way to prevent endometrial adenocarcinoma, but there are some things you can do to reduce your risk.

FAQs

1. What is the most common type of endometrial cancer?
   A: Endometrial adenocarcinoma

   

2. What are the symptoms of endometrial cancer?
   A: The most common symptom of endometrial cancer is vaginal bleeding after menopause. Other symptoms can include pelvic pain, abdominal pain, bloating, weight loss, and fatigue.

3. How is endometrial cancer diagnosed?
   A: Endometrial cancer is diagnosed with a biopsy. A biopsy is a procedure in which a small sample of tissue is removed from the uterus and examined under a microscope.

4. What are the treatment options for endometrial cancer?
   A: The treatment options for endometrial cancer include surgery, radiation therapy, chemotherapy, and hormone therapy.

5. What is the prognosis for endometrial cancer?
   A: The prognosis for endometrial cancer depends on the stage of the disease at the time of diagnosis. The 5-year survival rate for endometrial cancer is 95% for stage I, 85% for stage II, 70% for stage III, and 15% for stage IV.

6. How can I reduce my risk of endometrial cancer?
   A: There is no sure way to prevent endometrial cancer, but there are some things you can do to reduce your risk, such as maintaining a healthy weight, exercising regularly, eating a healthy diet, limiting alcohol intake, avoiding smoking, and getting regular Pap tests.